Vitamin D Protects Against Respiratory Infections, Confirms Study

87294891-5f2d-48dc-8537-29d8002c4261articleimage.jpg

16 Feb 2017 --- Vitamin D supplementation can protect against acute respiratory infections including colds and flu – that’s according to a major new study led by Queen Mary University of London (QMUL).

The study provides the most robust evidence yet that vitamin D has benefits beyond bone and muscle health, and could have major implications for public health policy, including the fortification of foods with vitamin D to tackle high levels of deficiency in the UK.

The results, published in the BMJ, are based on a new analysis of raw data from around 11,000 participants in 25 clinical trials conducted in 14 countries including the UK, USA, Japan, India, Afghanistan, Belgium, Italy, Australia and Canada.

Individually, these trials yielded conflicting results, with some reporting that vitamin D protected against respiratory infections, and others showing no effect.

Lead researcher Professor Adrian Martineau from QMUL said, “This major collaborative research effort has yielded the first definitive evidence that vitamin D really does protect against respiratory infections.”

“Our analysis of pooled raw data from each of the 10,933 trial participants allowed us to address the thorny question of why vitamin D ‘worked’ in some trials, but not in others.”

“The bottom line is that the protective effects of vitamin D supplementation are strongest in those who have the lowest vitamin D levels, and when supplementation is given daily or weekly rather than in more widely spaced doses.”

“Vitamin D fortification of foods provides a steady, low-level intake of vitamin D that has virtually eliminated profound vitamin D deficiency in several countries.”

“By demonstrating this new benefit of vitamin D, our study strengthens the case for introducing food fortification to improve vitamin D levels in countries such as the UK where profound vitamin D deficiency is common.”

Vitamin D – the “sunshine vitamin” – is thought to protect against respiratory infections by boosting levels of antimicrobial peptides - natural antibiotic-like substances – in the lungs.

Results of the study fit with the observation that colds and ‘flu are commonest in winter and spring, when levels of vitamin D are at their lowest. They may also explain why vitamin D protects against asthma attacks, which are commonly triggered by respiratory viruses.

Daily or weekly supplementation halved the risk of acute respiratory infection in people with the lowest baseline vitamin D levels, below 25 nanomoles per liter (nmol/L).

However, people with higher baseline vitamin D levels also benefited, although the effect was more modest (10 per cent risk reduction).

Overall, the reduction in risk of acute respiratory infection induced by vitamin D was on a par with the protective effect of injectable flu vaccine against flu-like illnesses.

Acute respiratory infections are a major cause of global morbidity and mortality. Upper respiratory infections such as colds and ‘flu are the commonest reason for GP consultations and days off work.

Acute lower respiratory infections such as pneumonia are less common, but caused an estimated 2.65 million deaths worldwide in 2013.

Vitamin D supplementation is safe and inexpensive, so reductions in acute respiratory infections brought about by vitamin D supplementation could be highly cost-effective.

The study was conducted by a consortium of 25 investigators from 21 institutions worldwide, and funded by the National Institute for Health Research.

Professor Hywel Williams, director of the NIHR Health Technology Assessment (HTA) Program said: “The interesting findings of this large study are worthy of serious further debate.”

“This study is yet another example of how the NIHR HTA Program reaches the parts that other research funders may not tackle.”

Related Articles

Nutrition & Health News

Dairy proteins take center stage at FiE 2017

12 Dec 2017 --- Exhibitors at FiE 2017 in Frankfurt showed a sustained focus on high protein concepts, with a number of notable innovations in the area of dairy-related ingredients. NutritionInsight looks at just a few of the offerings showcased at this year’s event.

Nutrition & Health News

EVNol Tocotrienol may beat omeprazole in controlling gastric issues

12 Dec 2017 --- ExcelVite’s EVNol tocotrienol was found to be more effective in treating gastric growth factors in stress-exposed rats than omeprazole, a common medication used in the treatment of gastroesophageal reflux disease and peptic ulcer disease. This is according to a recently published study in the World Journal of Gastroenterology that suggests more investigation is warranted.
 

Nutrition & Health News

Energetic growth: Energy boosters add pep to the nutritional space’s step

11 Dec 2017 --- Busy schedules can cause consumers to go through an “energy crisis” – prompting their desire to reach for products that might offer some support to their energy levels. Energy boosters are certainly showing signs of growth in all regions tracked by Innova Market Insights. A CAGR in supplement launches of +208.8 percent in South America from 2012 to 2016 is particularly noteworthy, while Europe is top of the pile worldwide with 28.8 percent of its supplement launches having an energy claim in 2016 and its CAGR amounting to a strong +86.7 percent.

Nutrition & Health News

Ingredion carbohydrate shows positive glycemic response and energy release results

06 Dec 2017 --- Ingredient solutions provider Ingredion Incorporated has announced the results of a new clinical study into the sustained energy effects of the Sustra 2434 slowly digestible carbohydrate. The study, published in the peer-reviewed scientific journal Nutrients, is the first to characterize physiological responses to the slowly digestible starch (SDS) in two different foods and found that it lowers glycemic response and produces a steadier energy release.

Business News

Kappa Bioscience reveals free vitamin K2 MK-7 quality testing program

06 Dec 2017 --- Kappa Bioscience has announced the worldwide launch of a free vitamin K2 MK-7 quality testing program. The program, announced at CPhI India, is open to finished K2 products, from any source, for testing and verification of the product’s K2 label claim. The program supports wider goals of educating markets about K2 stability and advancing K2 science to resolve the question of why unprotected K2 is unstable in mineral formulations. 

More Articles
URL : http://www.nutritioninsight.com:80/news/Vitamin-D-Protects-Against-Respiratory-Infections-Confirms-Study.html?type=article